Treatment of Acetabular Fractures in Elderly Patients (ACETA)

This retrospective study investigates surgical treatment of acetabular fractures in elderly patients (>60 years of age), either undergoing joint-preserving surgery or joint- replacement. 1 year- outcome with regard to mobility and autonomy is assessed.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

211

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Basel, Switzerland, 4031
        • Department of Orthopaedics and Trauma Surgery (DOTS).

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

56 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

patients with acetabular fracture between 2009 and 2018 treated at the Department of Orthopedic and Trauma Surgery of University Hospital Basel

Description

Inclusion Criteria:

  • surgical treatment of acetabular fracture between 2009 and 2018

Exclusion Criteria:

  • pathological fractures due to neoplasm or metastasis
  • status after implantation of an endoprosthesis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in living arrangements
Time Frame: at baseline (right after surgery) and 1 year after surgery
preservation of autonomy investigated by assessment of living arrangements: at home (by oneself, with a partner, with professional support), residential home for the elderly with occasional support, nursing home)
at baseline (right after surgery) and 1 year after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
number of rehospitalisations
Time Frame: single time point assessment 1 year after surgery
number of rehospitalisations
single time point assessment 1 year after surgery
number of re-surgeries
Time Frame: single time point assessment 1 year after surgery
number of re-surgeries
single time point assessment 1 year after surgery
mortality
Time Frame: single time point assessment 1 year after surgery
number of deaths
single time point assessment 1 year after surgery
infections
Time Frame: single time point assessment 1 year after surgery
number and type of infections
single time point assessment 1 year after surgery
Change in leg length difference
Time Frame: at baseline (right after surgery) and 1 year after surgery
radiological leg length difference (mm)
at baseline (right after surgery) and 1 year after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Franziska Saxer, Dr. med, Department of Orthopaedics and Traumatology, University Hospital Basel

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 27, 2019

Primary Completion (Actual)

June 2, 2020

Study Completion (Actual)

June 2, 2020

Study Registration Dates

First Submitted

April 24, 2019

First Submitted That Met QC Criteria

April 24, 2019

First Posted (Actual)

April 29, 2019

Study Record Updates

Last Update Posted (Actual)

June 4, 2020

Last Update Submitted That Met QC Criteria

June 2, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2019-00520; ch19Saxer2

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acetabular Fracture

Subscribe